A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan
Motoyoshi Yano(Nagoya University), Kei Ogata(Kurume University), Yoshimasa Kobayashi(Hamamatsu University School of Medicine), Yoshio Sumida(Kyoto Prefectural University of Medicine), Kentaro Yoshioka(Nagoya University), Fumiaki Kimura(Tamano General Medical College), Hisao Hayashi(Hokuriku University), Masahiko Kaito(Mie University), Hiroshi Yotsuyanagi(The University of Tokyo), Hiroyuki Saito(Asahikawa Medical College Hospital), Junji Kato(Sapporo Medical University), Yutaka Kohgo(Asahikawa Medical University), Kinya Kawamura(Hamamatsu University School of Medicine), Eiji Kajiwara(Nippon Steel Yawata Memorial Hospital), Shiro Iino(University of Fukui), Yoshiro Niitsu(Sapporo Medical University), Shinichi Kakumu(Aichi Medical University), Jiro Ikoma(Mie University), Shinya Wakusawa(Nagoya University), Michio Sata(Kurume University), Takeshi Okanoue(Yamaguchi University)
Cited by 63
Related Papers
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
|Journal of Hepatology|1999|2.9k
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan
|Hepatology|2001|418